9-FLUORO-11,17-DIHYDROXY-16-METHYL-3,20-DIOXOPREGNA-1,4-DIEN-21-AL, (11.BETA.,16.ALPHA.)-
UNII RT3MAJ5J6W
Substance Identification & Data
This profile provides standardized clinical and technical data for 9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-al, (11.beta.,16.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RT3MAJ5J6W.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2964-79-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H27FO5 RWXGMZVMPITTKC-CXSFZGCWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 9-fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-al, (11.beta.,16.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.